SCHEMBL27626526

SCHEMBL27626526

C[C](C)CCc1ccc(CO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.43
▸ NOS1 P29475 1/20 0.43
▸ CHKA P35790 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP4F2 P78329 1/20 0.38
▸ CYP4A11 Q02928 1/20 0.38
▸ PRSS1 P07477 1/20 0.38
▸ PRSS2 P07478 1/20 0.38
▸ PRSS3 P35030 1/20 0.38
▸ CA2 P00918 2/20 0.37
▸ FFAR1 O14842 2/20 0.37
▸ VHL P40337 1/20 0.37
▸ ELOC Q15369 1/20 0.37
▸ ELOB Q15370 1/20 0.37
▸ LTA4H P09960 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8214784 0.81 ALDH1A1 (0.65) NOS3NOS1CHKAALDH1A1CYP4F2
SCHEMBL7675448 0.80 ESR1 (0.62) TSHRALDH1A1CA2LTA4HESR1
SCHEMBL27576975 0.78 GFER (0.59) NOS3NOS1TSHRALDH1A1
SCHEMBL7946947 0.78 TAAR1 (0.50) ALDH1A1FFAR1
SCHEMBL9253136 0.78 TAAR1 (0.50) FFAR1
SCHEMBL28026743 0.78 TAAR1 (0.50) ALDH1A1FFAR1
SCHEMBL7539245 0.78 CHKA (0.58) NOS3NOS1CHKATSHRPRSS1
SCHEMBL16274 0.77 ALDH1A1 (0.67) ALDH1A1CA2FFAR1CA1HSD17B10
SCHEMBL6096653 0.75 F2RL1 (0.63) ALDH1A1FFAR1F2RL1
SCHEMBL12354595 0.74 F2RL1 (0.53) ALDH1A1CYP4F2CYP4A11FFAR1F2RL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1646508-A 5-substituted 1, 1-dioxo-1, 2, 5-thiadiazolidin-3-one derivatives as PTP-1B inhibitors NOVARTIS AG (CH) 2005-07-27 — — CN disclosed
Send feedback